サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1459777

足底筋膜炎治療市場：世界の産業分析、規模、シェア、成長、動向、予測、2023-2031年

Plantar Fasciitis Treatment Market (Type: Medication Therapy, Orthotics, Shockwave Therapy, Surgery, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日
ページ情報
英文 187 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.30円
足底筋膜炎治療市場：世界の産業分析、規模、シェア、成長、動向、予測、2023-2031年
出版日: 2024年02月20日
発行: Transparency Market Research
ページ情報: 英文 187 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

足底筋膜炎治療市場- 調査範囲

TMRの世界足底筋膜炎治療市場に関する調査レポートは、2023年から2031年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。2023年を基準年、2031年を予測年として、2017年から2031年までの世界の足底筋膜炎治療市場の収益と予測を提供します。また、2023年から2031年までの世界の足底筋膜炎治療市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されました。1次調査では、主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、足底筋膜炎治療市場を理解するために、主要企業の製品資料、年次報告書、プレスリリース、関連文書を参照しました。

市場スナップショット
2022年の市場価値 7億7,830万米ドル
2031年の市場価値 11億米ドル
CAGR 4.3%

当レポートでは、世界の足底筋膜炎治療市場の競合情勢について調査しています。世界の足底筋膜炎治療市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイリングされています。企業概要、財務状況、最近の市場開拓、SWOTは、本レポートで紹介されている世界の足底筋膜炎治療市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 市場概要
  • 市場力学
  • 世界市場分析と予測、2017-2031年

第5章 主要洞察

  • パイプライン分析
  • 主要製品/ブランド分析
  • 主要M&A
  • COVID-19パンデミックの産業への影響

第6章 世界市場分析と予測：タイプ別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：タイプ別、2017年～2031年
    • 薬物療法
      • 経口
      • 非経口
    • 衝撃波治療
      • 体外衝撃波治療（ESWT）
      • 体外空気圧衝撃波治療（IPST）
    • 外科手術
    • 装具
    • その他
  • 市場魅力度分析：タイプ別

第7章 世界市場分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：エンドユーザー別、2017年～2031年
    • 病院
    • クリニック
    • その他
  • 市場魅力度分析：エンドユーザー別

第8章 世界市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2017年～2031年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度分析：地域別

第9章 北米市場分析と予測

第10章 欧州市場分析と予測

第11章 アジア太平洋市場分析と予測

第12章 ラテンアメリカ市場分析と予測

第13章 中東・アフリカ市場分析と予測

第14章 競合情勢

  • 市場競合マトリックス（ティア別、企業規模別）
  • 市場シェア分析：企業別（2022年）
  • 企業プロファイル
    • Hanger, Inc.
    • Bayer Group（Dr. Scholl's）
    • A. Algeo Limited
    • Bauerfeind AG
    • Superfeet Worldwide, Inc.
    • Ottobock SE & Co. KGaA（Ottobock Holding）
    • Pfizer, Inc.
    • Sanofi
    • GlaxoSmithKline plc
図表

List of Tables

  • Table 01: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 02: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 03: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 04: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 05: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 06: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 08: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 11: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 12: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 13: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 14: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 15: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Middle East & Africa Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 17: Middle East & Africa Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 18: Middle East & Africa Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

List of Figures

  • Figure 01: Global Plantar Fasciitis Treatment Market Size (US$ Mn) and Distribution (%), by Region, 2022-2031
  • Figure 02: Global Plantar Fasciitis Treatment Market Revenue (US$ Mn), by Type, 2022
  • Figure 03: Global Plantar Fasciitis Treatment Market Value Share, by Type, 2022
  • Figure 04: Global Plantar Fasciitis Treatment Market Revenue (US$ Mn), by End-user, 2022
  • Figure 05: Global Plantar Fasciitis Treatment Market Value Share, by End-user, 2022
  • Figure 06: Global Plantar Fasciitis Treatment Market Value Share, by Region, 2022
  • Figure 07: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 08: Global Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022-2031
  • Figure 09: Global Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 10: Global Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022-2031
  • Figure 11: Global Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 12: Global Plantar Fasciitis Treatment Market Value Share Analysis, by Region, 2022-2031
  • Figure 13: Global Plantar Fasciitis Treatment Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 14: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 15: North America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 16: North America Plantar Fasciitis Treatment Market Value Share Analysis, by Country, 2022-2031
  • Figure 17: North America Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022-2031
  • Figure 18: North America Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022-2031
  • Figure 19: North America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 20: North America Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 21: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 22: Europe Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 23: Europe Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 24: Europe Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022-2031
  • Figure 25: Europe Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022-2031
  • Figure 26: Europe Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 27: Europe Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 28: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 29: Asia Pacific Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 30: Asia Pacific Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 31: Asia Pacific Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022-2031
  • Figure 32: Asia Pacific Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022-2031
  • Figure 33: Asia Pacific Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 34: Asia Pacific Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 35: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 36: Latin America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 37: Latin America Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 38: Latin America Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022-2031
  • Figure 39: Latin America Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022-2031
  • Figure 40: Latin America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 41: Latin America Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 42: Middle East & Africa Plantar Fasciitis Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 43: Middle East & Africa Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 44: Middle East & Africa Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 45: Middle East & Africa Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022-2031
  • Figure 46: Middle East & Africa Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022-2031
  • Figure 47: Middle East & Africa Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 48: Middle East & Africa Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
目次
Product Code: TMRGL47658

Plantar Fasciitis Treatment Market - Scope of Report

TMR's report on the global plantar fasciitis treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global plantar fasciitis treatment market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global plantar fasciitis treatment market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the plantar fasciitis treatment market.

Market Snapshot
Market Value in 2022US$ 778.3 Mn
Market Value in 2031US$ 1.1 Bn
CAGR4.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global plantar fasciitis treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global plantar fasciitis treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global plantar fasciitis treatment market.

The report delves into the competitive landscape of the global plantar fasciitis treatment market. Key players operating in the global plantar fasciitis treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global plantar fasciitis treatment market profiled in this report.

Key Questions Answered in Global plantar fasciitis treatment Market Report:

  • What is the sales/revenue generated by plantar fasciitis treatment across all regions during the forecast period?
  • What are the opportunities in the global plantar fasciitis treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Plantar Fasciitis Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global plantar fasciitis treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global plantar fasciitis treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global plantar fasciitis treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Plantar Fasciitis Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Plantar Fasciitis Treatment Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Type, 2017-2031
    • 6.3.1. Medication Therapy
      • 6.3.1.1. Oral
      • 6.3.1.2. Parenteral
    • 6.3.2. Shockwave Therapy
      • 6.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
      • 6.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
    • 6.3.3. Surgery
    • 6.3.4. Orthotics
    • 6.3.5. Others
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by End-user, 2017-2031
    • 7.3.1. Hospitals
    • 7.3.2. Clinics
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by End-user

8. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region, 2017-2031
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Plantar Fasciitis Treatment Market Analysis and Forecast

  • 9.1. Introduction
  • 9.2. Key Findings
  • 9.3. Market Value Forecast, by Type, 2017-2031
    • 9.3.1. Medication Therapy
      • 9.3.1.1. Oral
      • 9.3.1.2. Parenteral
    • 9.3.2. Shockwave Therapy
      • 9.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
      • 9.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
    • 9.3.3. Surgery
    • 9.3.4. Orthotics
    • 9.3.5. Others
  • 9.4. Market Value Forecast, by End-user, 2017-2031
    • 9.4.1. Hospitals
    • 9.4.2. Clinics
    • 9.4.3. Others
  • 9.5. Market Value Forecast, by Country, 2017-2031
    • 9.5.1. U.S.
    • 9.5.2. Canada
  • 9.6. Market Attractiveness Analysis
    • 9.6.1. By Type
    • 9.6.2. By End-user
    • 9.6.3. By Country

10. Europe Plantar Fasciitis Treatment Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Type, 2017-2031
    • 10.3.1. Medication Therapy
      • 10.3.1.1. Oral
      • 10.3.1.2. Parenteral
    • 10.3.2. Shockwave Therapy
      • 10.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
      • 10.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
    • 10.3.3. Surgery
    • 10.3.4. Orthotics
    • 10.3.5. Others
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. Clinics
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.5.1. Germany
    • 10.5.2. U.K.
    • 10.5.3. France
    • 10.5.4. Italy
    • 10.5.5. Spain
    • 10.5.6. Rest of Europe
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By End-user
    • 10.6.3. By Country/Sub-region

11. Asia Pacific Plantar Fasciitis Treatment Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Type, 2017-2031
    • 11.3.1. Medication Therapy
      • 11.3.1.1. Oral
      • 11.3.1.2. Parenteral
    • 11.3.2. Shockwave Therapy
      • 11.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
      • 11.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
    • 11.3.3. Surgery
    • 11.3.4. Orthotics
    • 11.3.5. Others
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. Clinics
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. China
    • 11.5.2. Japan
    • 11.5.3. India
    • 11.5.4. Australia & New Zealand
    • 11.5.5. Rest of Asia Pacific
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By End-user
    • 11.6.3. By Country/Sub-region

12. Latin America Plantar Fasciitis Treatment Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Type, 2017-2031
    • 12.3.1. Medication Therapy
      • 12.3.1.1. Oral
      • 12.3.1.2. Parenteral
    • 12.3.2. Shockwave Therapy
      • 12.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
      • 12.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
    • 12.3.3. Surgery
    • 12.3.4. Orthotics
    • 12.3.5. Others
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. Clinics
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. Brazil
    • 12.5.2. Mexico
    • 12.5.3. Rest of Latin America
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By End-user
    • 12.6.3. By Country/Sub-region

13. Middle East & Africa Plantar Fasciitis Treatment Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Type, 2017-2031
    • 13.3.1. Medication Therapy
      • 13.3.1.1. Oral
      • 13.3.1.2. Parenteral
    • 13.3.2. Shockwave Therapy
      • 13.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
      • 13.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
    • 13.3.3. Surgery
    • 13.3.4. Orthotics
    • 13.3.5. Others
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. Clinics
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. GCC Countries
    • 13.5.2. South Africa
    • 13.5.3. Rest of Middle East & Africa
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By End-user
    • 13.6.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 14.2. Market Share Analysis, by Company (2022)
  • 14.3. Company Profiles
    • 14.3.1. Hanger, Inc.
      • 14.3.1.1. Company Overview
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. SWOT Analysis
      • 14.3.1.4. Financial Overview
      • 14.3.1.5. Strategic Overview
    • 14.3.2. Bayer Group (Dr. Scholl's)
      • 14.3.2.1. Company Overview
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. SWOT Analysis
      • 14.3.2.4. Financial Overview
      • 14.3.2.5. Strategic Overview
    • 14.3.3. A. Algeo Limited
      • 14.3.3.1. Company Overview
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. SWOT Analysis
      • 14.3.3.4. Financial Overview
      • 14.3.3.5. Strategic Overview
    • 14.3.4. Bauerfeind AG
      • 14.3.4.1. Company Overview
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. SWOT Analysis
      • 14.3.4.4. Financial Overview
      • 14.3.4.5. Strategic Overview
    • 14.3.5. Superfeet Worldwide, Inc.
      • 14.3.5.1. Company Overview
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. SWOT Analysis
      • 14.3.5.4. Financial Overview
      • 14.3.5.5. Strategic Overview
    • 14.3.6. Ottobock SE & Co. KGaA (Ottobock Holding)
      • 14.3.6.1. Company Overview
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. SWOT Analysis
      • 14.3.6.4. Financial Overview
      • 14.3.6.5. Strategic Overview
    • 14.3.7. Pfizer, Inc.
      • 14.3.7.1. Company Overview
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. SWOT Analysis
      • 14.3.7.4. Financial Overview
      • 14.3.7.5. Strategic Overview
    • 14.3.8. Sanofi
      • 14.3.8.1. Company Overview
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. SWOT Analysis
      • 14.3.8.4. Financial Overview
      • 14.3.8.5. Strategic Overview
    • 14.3.9. GlaxoSmithKline plc
      • 14.3.9.1. Company Overview
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. SWOT Analysis
      • 14.3.9.4. Financial Overview
      • 14.3.9.5. Strategic Overview